Sfoglia per Autore
Real time RT-PCR determination of mRNA levels of cytokine, chemokine and chemokine receptors in PBLs from MS patients: clinical and MRI correlations
2003-01-01 Furlan, R; Rovaris, M; Bergami, A; Martinelli Boneschi, F; Gironi, M; Kurne, A; Deleidi, M; Agosta, F; Comi, G; Filippi, M; Martino, G.
Serial immunoprecipitation assays for interferon (IFN) beta antibodies in multiple sclerosis patients
2003-01-01 Lampasona, V; Rio, J; Franciotta, D; Furlan, R; Avolio, C; Fazio, R; Lavolpe, V; Vincent, A; Comi, Giancarlo; Trojano, M; Montalban, X; Martino, Gianvito
Cytokine gene delivery into the central nervous system using intrathecally injected non-replicative viral vectors
2003-01-01 Furlan, R; Pluchino, S; Marconi, Pc; Martino, Gianvito
Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis
2003-01-01 Furlan, R; Brambilla, E; Sanvito, F; Roccatagliata, L; Olivieri, S; Bergami, A; Pluchino, S; Uccelli, A; Comi, Giancarlo; Martino, Gianvito
The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system
2003-01-01 Furlan, R; Pluchino, S; Martino, Gianvito
Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis
2003-01-01 Pluchino, S; Quattrini, A; Brambilla, E; Gritti, A; Salani, G; Dina, G; Galli, R; Del Carro, U; Amadio, S; Bergami, A; Furlan, R; Comi, G; Vescovi, Al; Martino, Gianvito
beta endorphin concentrations in PBMC of patients with different clinical phenotypes of multiple sclerosis
2003-01-01 Gironi, M; Furlan, R; Rovaris, M; Comi, Giancarlo; Filippi, Massimo; Panerai, Ae; Sacerdote, P.
Gene therapy-mediated modulation of immune processes in the central nervous system
2003-01-01 Furlan, R; Pluchino, S; Martino, Gianvito
Activation of invariant NKT cells by alpha GalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma
2003-01-01 Furlan, R; Bergami, A; Cantarella, D; Brambilla, E; Taniguchi, M; Dellabona, P; Casorati, G; Martino, Gianvito
Clinical and functional recovery from experimental autoimmune encephalomyelitis by intracisternal delivery of IL4 from a helper-dependent adenoviral vector. A pre-clinical model of gene therapy of multiple sclerosis
2004-01-01 Butti, E; Recchia, A; Bergami, A; Stornaiuolo, A; Brambilla, E; Furlan, R; Martino, G; Mavilio, F
Adenovirus-mediated IL-4 transfer is protective in ischemia/reperfusion brain injury
2004-01-01 Perego, C; Echart, C; Rossi, E; Butti, E; Furlan, R; Veglianese, P; Martino, G; De Simoni, Mg
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects
2004-01-01 Lampasona, V; Franciotta, D; Furlan, R; Zanaboni, S; Fazio, R; Bonifacio, E; Comi, G; Martino, G
TNFα in experimental diseases of the CNS
2004-01-01 Furlan, R; Villa, P; Senaldi, G; Martino, Gianvito
Detection of TNF and TNF Receptor mRNA in Cells and Tissues
2004-01-01 Furlan, R; Salani, G; Bergami, A; Martino, Gianvito
Immunological patterns identifying disease course and disease evolution in multiple sclerosis patients
2004-01-01 Furlan, R; Rovaris, M; Boneschi, Fm; Khademi, M; Bergami, A; Gironi, M; Deleidi, M; Agosta, F; Franciotta, D; Scarpini, E; Uccelli, A; Zaffaroni, M; Kurne, A; Comi, G; Olsson, T; Filippi, M; Martino, G
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis
2004-01-01 Furlan, R; Kurne, A; Bergami, A; Brambilla, E; Maucci, R; Gasparini, L; Butti, E; Ongini, E; Comi, G; Martino, G
Gene therapy for autoimmune diseases
2004-01-01 Furlan, R; Butti, E; Pluchino, S; Martino, Gianvito
alpha-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis
2004-01-01 Morini, M; Roccatagliata, L; Dell'Eva, R; Pedemonte, E; Furlan, R; Minghelli, S; Giunti, D; Pfeffer, U; Marchese, M; Noonan, D; Mancardi, G; Albini, A; Uccelli, A
Study of putative pathways for central nervous system homing of systemically-injected neural precursor cells in mice affected with experimental autoimmune encephalomyelitis
2004-01-01 Stefano, P; Zanotti, L; Brambilla, E; Rossi, B; Ottoboni, L; Martinello, M; Deleidi, M; Furlan, R; Comi, G; Constantin, G; Martino, G
Motor-evoked potentials (MEPs) for monitoring chronic cortico-spinal damage in MOG35-55-induced experimental autoimmune encephalomyelitis (EAE)
2004-01-01 Amadio, S; Brambilla, E; Brini, B; Muzio, V; Pluchino, S; Furlan, R; Comi, G; Zaratin, P; Martino, G; Del Carro, U
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Real time RT-PCR determination of mRNA levels of cytokine, chemokine and chemokine receptors in PBLs from MS patients: clinical and MRI correlations | 1-gen-2003 | Furlan, R; Rovaris, M; Bergami, A; Martinelli Boneschi, F; Gironi, M; Kurne, A; Deleidi, M; Agosta, F; Comi, G; Filippi, M; Martino, G. | |
Serial immunoprecipitation assays for interferon (IFN) beta antibodies in multiple sclerosis patients | 1-gen-2003 | Lampasona, V; Rio, J; Franciotta, D; Furlan, R; Avolio, C; Fazio, R; Lavolpe, V; Vincent, A; Comi, Giancarlo; Trojano, M; Montalban, X; Martino, Gianvito | |
Cytokine gene delivery into the central nervous system using intrathecally injected non-replicative viral vectors | 1-gen-2003 | Furlan, R; Pluchino, S; Marconi, Pc; Martino, Gianvito | |
Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis | 1-gen-2003 | Furlan, R; Brambilla, E; Sanvito, F; Roccatagliata, L; Olivieri, S; Bergami, A; Pluchino, S; Uccelli, A; Comi, Giancarlo; Martino, Gianvito | |
The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system | 1-gen-2003 | Furlan, R; Pluchino, S; Martino, Gianvito | |
Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis | 1-gen-2003 | Pluchino, S; Quattrini, A; Brambilla, E; Gritti, A; Salani, G; Dina, G; Galli, R; Del Carro, U; Amadio, S; Bergami, A; Furlan, R; Comi, G; Vescovi, Al; Martino, Gianvito | |
beta endorphin concentrations in PBMC of patients with different clinical phenotypes of multiple sclerosis | 1-gen-2003 | Gironi, M; Furlan, R; Rovaris, M; Comi, Giancarlo; Filippi, Massimo; Panerai, Ae; Sacerdote, P. | |
Gene therapy-mediated modulation of immune processes in the central nervous system | 1-gen-2003 | Furlan, R; Pluchino, S; Martino, Gianvito | |
Activation of invariant NKT cells by alpha GalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma | 1-gen-2003 | Furlan, R; Bergami, A; Cantarella, D; Brambilla, E; Taniguchi, M; Dellabona, P; Casorati, G; Martino, Gianvito | |
Clinical and functional recovery from experimental autoimmune encephalomyelitis by intracisternal delivery of IL4 from a helper-dependent adenoviral vector. A pre-clinical model of gene therapy of multiple sclerosis | 1-gen-2004 | Butti, E; Recchia, A; Bergami, A; Stornaiuolo, A; Brambilla, E; Furlan, R; Martino, G; Mavilio, F | |
Adenovirus-mediated IL-4 transfer is protective in ischemia/reperfusion brain injury | 1-gen-2004 | Perego, C; Echart, C; Rossi, E; Butti, E; Furlan, R; Veglianese, P; Martino, G; De Simoni, Mg | |
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects | 1-gen-2004 | Lampasona, V; Franciotta, D; Furlan, R; Zanaboni, S; Fazio, R; Bonifacio, E; Comi, G; Martino, G | |
TNFα in experimental diseases of the CNS | 1-gen-2004 | Furlan, R; Villa, P; Senaldi, G; Martino, Gianvito | |
Detection of TNF and TNF Receptor mRNA in Cells and Tissues | 1-gen-2004 | Furlan, R; Salani, G; Bergami, A; Martino, Gianvito | |
Immunological patterns identifying disease course and disease evolution in multiple sclerosis patients | 1-gen-2004 | Furlan, R; Rovaris, M; Boneschi, Fm; Khademi, M; Bergami, A; Gironi, M; Deleidi, M; Agosta, F; Franciotta, D; Scarpini, E; Uccelli, A; Zaffaroni, M; Kurne, A; Comi, G; Olsson, T; Filippi, M; Martino, G | |
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis | 1-gen-2004 | Furlan, R; Kurne, A; Bergami, A; Brambilla, E; Maucci, R; Gasparini, L; Butti, E; Ongini, E; Comi, G; Martino, G | |
Gene therapy for autoimmune diseases | 1-gen-2004 | Furlan, R; Butti, E; Pluchino, S; Martino, Gianvito | |
alpha-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis | 1-gen-2004 | Morini, M; Roccatagliata, L; Dell'Eva, R; Pedemonte, E; Furlan, R; Minghelli, S; Giunti, D; Pfeffer, U; Marchese, M; Noonan, D; Mancardi, G; Albini, A; Uccelli, A | |
Study of putative pathways for central nervous system homing of systemically-injected neural precursor cells in mice affected with experimental autoimmune encephalomyelitis | 1-gen-2004 | Stefano, P; Zanotti, L; Brambilla, E; Rossi, B; Ottoboni, L; Martinello, M; Deleidi, M; Furlan, R; Comi, G; Constantin, G; Martino, G | |
Motor-evoked potentials (MEPs) for monitoring chronic cortico-spinal damage in MOG35-55-induced experimental autoimmune encephalomyelitis (EAE) | 1-gen-2004 | Amadio, S; Brambilla, E; Brini, B; Muzio, V; Pluchino, S; Furlan, R; Comi, G; Zaratin, P; Martino, G; Del Carro, U |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile